Neurocrine Biosciences, Inc. (NBIX) Technical Analysis & Indicators

Neurocrine Biosciences, Inc. (NBIX) — Price $164.85 (closing price, November 3, 2026) — Healthcare — Biotechnology — NASDAQ

Latest reported results:

Technical analysis of Neurocrine Biosciences, Inc. (NBIX): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.

Neurocrine Biosciences, Inc. is a pharmaceutical firm dedicated to the creation, advancement, and commercialization of medicines addressing a spectrum of neurological, endocrine, and psychiatric conditions. Its current therapeutic pipeline and marketed products target disorders such as tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, alongside numerous experimental compounds in various clinical stages.

Price Performance

1 month+14.31%
3 months+3.15%
Year-to-date+16.23%
1 year+15.13%
3 years+46.61%
5 years+76.86%
10 years+298.67%

52-Week Range

52-week High$186.12
52-week Low$122.14
Avg Volume (90d)1.3M

Technical Indicators

SMA 50$146.72
SMA 200$147.60
Beta0.35
30-day Volatility (annualised)43.0%
Price vs SMA 50+12.4%
Price vs SMA 200+11.7%

Monthly Close (12 months)

MonthCloseChange
2025-12$141.83
2026-01$136.06-4.1%
2026-02$132.25-2.8%
2026-03$131.74-0.4%
2026-04$131.67-0.1%
2026-05$158.30+20.2%
2026-06$168.54+6.5%
2026-07$166.80-1.0%
2026-08$154.03-7.7%
2026-09$141.84-7.9%
2026-10$146.10+3.0%
2026-11$164.85+12.8%

Upcoming Earnings

DateEPS Est.Revenue Est.
2026-11-02$1.91$1.04B
2026-07-30$1.85$890M
2026-05-05$1.22$768M
2026-02-11$1.80$790M
2025-10-28$1.58$807M
2025-07-30$0.98$746M

Price

Price$164.85 (closing price, November 3, 2026)
Market Cap$16.8B
ExchangeNASDAQ
CountryUS

Valuation Ratios

P/E Ratio24.46
Price / Book4.32
Dividend Yield0.00%

Financial Health

Debt / Equity0.10
Current Ratio2.04
Piotroski F-Score6
Altman Z-Score7.80

Related companies: JAZZ · AXSM · ACAD · BHVN

Explore sector: Healthcare · Biotechnology

More sections of NBIX: Overview · Financials · Valuation · Estimates · Ownership

Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks